New eye drop battle: which offers better dry eye relief?
NCT ID NCT07593885
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two preservative-free eye drops, Artelac Complete MDO and VISMED MULTI, for treating moderate to severe dry eye disease. About 160 adults who have used tear substitutes for at least a month will use one of the two drops for 90 days. Researchers will measure changes in dry eye symptoms and check for side effects to see if the new drop works as well as the current one.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Augen & Haut Zentrum-Praxis Dr. Jacobi
RECRUITINGNuremberg, Bavaria, 90403, Germany
-
Augen-Zentrum-Nordwest
NOT_YET_RECRUITINGAhaus, North Rhine-Westphalia, 48683, Germany
-
Chiemsee Augentagesklinik, Prien
NOT_YET_RECRUITINGBad Endorf, Bavaria, 83093, Germany
-
University Saarland Medical Center
NOT_YET_RECRUITINGHomburg, Saarland, 66421, Germany
-
Universitäts-Augenklinik Heidelberg
NOT_YET_RECRUITINGHeidelberg, Baden-Wurttemberg, 69120, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can a new eye drop soothe severe dry eye?
- Can a new drug ease the dryness, pain, and fatigue of Sjögren's disease?
- New imaging tools put to the test for measuring dry eye treatment effects
- Could a special screen light reduce tired eyes and dryness?
- Nasal spray could make contact lenses more comfortable